Statins linked to 20% lower colorectal cancer risk

Statins used in the general population conferred a 20% risk reduction for colorectal cancer with a possibly larger impact in patients with inflammatory bowel disease, according to an analysis presented during ACG 2020 Virtual.“We found that statin use was associated with a significant risk reduction of colorectal cancer in the non-IBD population whereby the risk reduction was 20%,” Kevin N. Singh, MD, from NYU Langone Medical Center, said during his virtual presentation. “We found that statin users were noted to have a 60% lower risk of colorectal cancer in the IBD population.”Read More

Share on facebook
Share on twitter
Share on linkedin